Literature DB >> 24068584

The impact of personality disorders on legally supervised community treatment: a systematic literature review.

W Amory Carr1.   

Abstract

Mental health needs are common among community corrections offenders and many are enrolled in some form of supervised or mandated treatment. One category of mental health problem which may be germane to both treatment completion and recidivism among those in legally supervised treatment is the diagnosis of Personality Disorder (PD). This systematic review reports on sixteen studies comprised of full or mixed legally-supervised samples of offender in community-based treatment and examines the impact of PDs on treatment completion. These studies were difficult to compare because of the differences in program setting, definition of treatment completion, definition of PD, method of PD assessment and type of treatment, among other variables. The impact of antisocial personality disorder in treatment was a common focus, and other PDs were rarely assessed. The relevance of DSM PD categories to offender management in community corrections as well as the limitations of the current PD diagnostic categories is discussed.

Entities:  

Mesh:

Year:  2013        PMID: 24068584     DOI: 10.1007/s10597-013-9649-8

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  36 in total

Review 1.  Toward DSM-V and the classification of psychopathology.

Authors:  T A Widiger; L A Clark
Journal:  Psychol Bull       Date:  2000-11       Impact factor: 17.737

Review 2.  Co-morbidity of personality disorders in individuals with substance use disorders.

Authors:  R Verheul
Journal:  Eur Psychiatry       Date:  2001-08       Impact factor: 5.361

3.  The prevalence of DSM-IV personality disorders in psychiatric outpatients.

Authors:  Mark Zimmerman; Louis Rothschild; Iwona Chelminski
Journal:  Am J Psychiatry       Date:  2005-10       Impact factor: 18.112

4.  Axis I and axis II comorbidity in alcohol dependence and the two types of alcoholism.

Authors:  M Driessen; C Veltrup; T Wetterling; U John; H Dilling
Journal:  Alcohol Clin Exp Res       Date:  1998-02       Impact factor: 3.455

5.  The impact of borderline personality disorder on residential substance abuse treatment dropout among men.

Authors:  Matthew T Tull; Kim L Gratz
Journal:  Drug Alcohol Depend       Date:  2011-09-09       Impact factor: 4.492

6.  Personality disorders in drug abusers: prevalence and their association with AXIS I disorders as predictors of treatment retention.

Authors:  A Kokkevi; N Stefanis; E Anastasopoulou; C Kostogianni
Journal:  Addict Behav       Date:  1998 Nov-Dec       Impact factor: 3.913

7.  Differential diagnosis of personality disorders by the seven-factor model of temperament and character.

Authors:  D M Svrakic; C Whitehead; T R Przybeck; C R Cloninger
Journal:  Arch Gen Psychiatry       Date:  1993-12

8.  Measuring disordered personality functioning: to love and to work reprised.

Authors:  G Parker; D Hadzi-Pavlovic; L Both; S Kumar; K Wilhelm; A Olley
Journal:  Acta Psychiatr Scand       Date:  2004-09       Impact factor: 6.392

9.  Severity Indices of Personality Problems (SIPP-118): development, factor structure, reliability, and validity.

Authors:  Roel Verheul; Helene Andrea; Caspar C Berghout; Conor Dolan; Jan J V Busschbach; Petra J A van der Kroft; Anthony W Bateman; Peter Fonagy
Journal:  Psychol Assess       Date:  2008-03

10.  The interactive effects of antisocial personality disorder and court-mandated status on substance abuse treatment dropout.

Authors:  Stacey B Daughters; Brooke A Stipelman; Marsha N Sargeant; Randi Schuster; Marina A Bornovalova; C W Lejuez
Journal:  J Subst Abuse Treat       Date:  2007-09-14
View more
  1 in total

1.  Criminalization Through Transinstitutionalization: A Critical Review of the Penrose Hypothesis in the Context of Compensation Imprisonment.

Authors:  Sebastian Schildbach; Carola Schildbach
Journal:  Front Psychiatry       Date:  2018-10-25       Impact factor: 4.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.